The COVID-19 pandemic and the science aimed at bringing it to an end

The Buck is the world’s premier scientific research institute focused solely on the biology of aging. For more than 20 years our mission has been to end the threat of age-related disease to help people live better longer. Because the novel coronavirus disproportionately impacts adults over 60 we know that our expertise is critical, and that is why we have refocused the work of many of our labs to join the fight against COVID-19.

During this time of disruption, we are eager to lean into our scientific expertise to fight this virus – a fight which includes a commitment to provide the public with evidence-based information on health and disease.

These recent Conversations at the Buck bring together colleagues inside and outside of the Buck who have important perspectives on how to think about, deal with, and potentially treat this pandemic. We feel privileged to be able to share their insights with you in this special web series focused on COVID-19.

View these recent evidence-based conversations for insights into how scientists are thinking about, dealing with and working to stop the COVID-19 pandemic.


Eric Verdin, MD

President and CEO, Buck Institute

Professor of Medicine, University of California, San Francisco


Larry Brilliant, MD, MPH

Chair, Ending Pandemics


Melanie Ott, MD, PhD

Senior Investigator, Gladstone Institute of Virology and Immunology

Professor, Medicine, University of California, San Francisco

John Newman, MD, PhD

Assistant Professor, Buck Institute for Research on Aging

Assistant Professor, Division of Geriatrics, UCSF Medicine

Nevan Krogan, PhD

Director, Quantitative Biosciences Institute at University of California San Francisco

Director, Gladstone Institute
Adjunct faculty, Buck Institute

Adjunct faculty, Buck Institute

These sessions are not intended to provide medical advice.
Please consult with your personal physician.

Looking for more information about this conversation series?

Email us at: